Spotlight On
<ѻýҕl class="page-description">ѻýҕl>Latest in Spotlight On
Until 2017, no FDA approved options existed for serious side effect of dopamine-blocking drugs
Aug 13, 2024
Clinicians need to rely on prescribing practices that minimize risk of development, says expert
Aug 13, 2024
With results that matter for patients, the mandate for testing is growing
Aug 01, 2024
Long-term treatment can present significant challenges
Aug 01, 2024
With results that matter for patients, the mandate for testing is growing
Aug 01, 2024
Long-term treatment can present significant challenges
Aug 01, 2024
More in Spotlight On
PCPs are "perfectly situated" to identify initial thinking changes of patients, expert says
Jul 05, 2024